<mods:mods xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd" version="3.3" xmlns:mods="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><mods:titleInfo><mods:title>CLINICAL PHENOTYPES AND MORTALITY RATES OF ALCOHOLIC LIVER CIRRHOSIS IN PATIENTS WITH PREVIOUS COVID-19 INFECTION</mods:title></mods:titleInfo><mods:name type="personal"><mods:namePart type="given"></mods:namePart><mods:namePart type="family">X.S.Shodmonova</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:abstract>Clinical phenotypes and mortality rates of alcoholic liver cirrhosis in patients with previous COVID-19 infection. This study investigated the clinical phenotypes and mortality outcomes in patients with alcoholic liver cirrhosis (ALC) and a history of COVID-19 infection. A retrospective-prospective observational study was conducted between 2022 and 2024 at the Bukhara Regional Clinical Hospital. A total of 120 patients were analyzed: 68 with prior COVID-19 infection and 52 as controls. The findings revealed that ALC patients with COVID-19 had higher rates of Child-Pugh C (46% vs. 25%, p=0.02), higher MELD scores (19.3 ± 5.2 vs. 15.1 ± 4.7, p=0.01), and increased mortality (35.3% vs. 17.3%, p=0.03). These results suggest that COVID-19 aggravates the clinical course of alcoholic liver cirrhosis, leading to more severe phenotypes and higher mortality</mods:abstract><mods:originInfo><mods:dateIssued encoding="iso8601">2026-02-02</mods:dateIssued></mods:originInfo><mods:originInfo><mods:publisher>South Aral Region Medical Journal</mods:publisher></mods:originInfo><mods:genre>Maqola</mods:genre></mods:mods>